Abstract
Objective
To report a retrospective, single-center experience with a novel deep brain stimulation (DBS) device capable of chronic local field potential (LFP) recording in drug-resistant epilepsy (DRE) and explore potential electrophysiological biomarkers that may aid DBS programming and outcome tracking.
Methods
Five patients with DRE underwent thalamic DBS, targeting either the bilateral anterior (ANT; n=3) or centromedian (CM; n=2) nuclei. Post-operative electrode lead localizations were visualized in Lead-DBS software. Local field potentials recorded over 12-18 months were tracked and changes in power were ...
Seguir leyendo →JUL